
Responsible for technical evaluation of extractable and leachable studies to ensure that acceptable data is generated to support FDA drug applications. This role will be responsible for providing technical training to other scientists and will serve as a subject matter expert for mass spectrometry and extractable and leachable.
Salary Range: $90,000 - $100,000
Applicants must be authorized to work for ANY employer in the United States. Fresenius Kabi is unable to sponsor or take over sponsorship of an employment visa either now or in the future.
This position is eligible for a $2,000 sign-on bonus
The Scientist reviews extractable/leachable study design concepts to meet regional requirements (i.e., USP and or ISO 10993).
Performs Extractable and Leachable testing in the lab, which includes method development, Method validation, and stability testing in a cGMP environment.
Acts as a subject matter expert in mass spectrometry and extractable/leachable
Operates and troubleshoots the GC/MS, HR-LC/MS, and other analytical methods used for extractable and leachable Testing in a cGMP environment.
Evaluate analytical results and identify trends/exceptions/interpretations of results relative to chemical characterization, product requirements, and toxicological assessment.
Draft, review, and approve E&L analytical testing protocols and reports.
Performs mass spectral interpretation and unknown compound identification.
Prepares E&L studies and safety assessment summaries for regulatory dossiers.
Understand and effectively communicate the strategic focus and plan to team members.
Communicates clearly with the manager, peers, cross-functional teammates, and non-technical audiences by openly sharing project status and hurdles while seeking input from other team members.
Bachelor’s degree in Pharmaceutical Sciences, Chemistry, Biological Sciences with 5+ years of related experience or a master’s degree in Pharmaceutical Sciences, Chemistry, Biological Sciences with 3+years of related experience or a PhD in Pharmaceutical Sciences, Chemistry, Biological Sciences, Chemical/Biomedical Engineering with one to three years of related experience is required.
qualification/validation under a cGMP environment is highly preferable.
independently, with others, and as part of a team. Expected to execute all E&L projects with detail and discipline and achieve all project milestones on time.
Provided constructive feedback to E&L and analytical colleagues and motivated other team members as required. Candidate should be able to write, review, and approve analytical methods, validation protocols and reports, E&L testing reports, SOPs, technical memos, Investigation reports, change control, and E&L part of the regulatory dossiers.
· The Company’s primary business language is English. The successful candidate must be able to effectively speak, read, write, and understand English to perform the essential functions of the position, including independently understanding policies, procedures, training materials, and workplace communications written in English due to our heavily regulated work environment.
We offer an excellent salary and benefits package including medical, dental and vision coverage, as well as life insurance, disability, 401K with company contribution, and wellness program.
Please note that joining our team does not create a guaranteed or permanent employment arrangement. All employment is at‑will, meaning both the employee and Fresenius Kabi have the right to end the employment relationship at any time, in accordance with applicable federal and state laws.
Fresenius Kabi is an Equal Opportunity/Affirmative Action employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, citizenship, immigration status, disabilities, or protected veteran status.

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.
In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.
Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.
Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale.
User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions
Imprint: www.fresenius-kabi.com/imprint